Comparison of the Effect of Intensive versus Conventional Insulinotherapy in Patients with Cardiac Surgery after Cardiopulmonary Bypass

10.4077/CJP.2013.BAA078

Huey-Ling Liou；Chun-Che Shih；Kwei-Chun Chung；Hsing-I Chen

cardiac surgery patients ； cardiopulmonary bypass ； intensive insulinotherapy

The Chinese Journal of Physiology

56卷2期（2013 / 04 / 01）

101 - 109

英文

Hyperglycemia occurs commonly in clinically ill patients. Insulin therapy and glycemic control have been recommended for patients with septic shock. The present study investigated the effect of intensive (INIT) versus conventional insulinotherapy (COIT) in cardiac surgery patients who received cardiopulmonary bypass (CPB). In this quasi-experimental study, a total of 50 patients undergoing coronary artery bypass grafting (CABG) were recruited into the INIT and COIT groups. Study measures included serum glucose levels, cardiac output, cytokines, C-reactive protein (CRP), duration of mechanical ventilation and length of stay in the intensive care unit (ICU), and ICU mortality rate. In the INIT group, mean blood glucose level during the first two postoperative days was significantly lower than that in the COIT group. Cardiac output was significantly greater at the second postoperative days in the INIT patients than those in the COIT group. There were no differences in cytokines, CRP levels and the outcome data between two groups. Intensive insulinotherapy reduced the blood glucose and led to improve cardiac output after CABG in comparison with conventional insulinotherapy.

1. Biffl, W.L.,Moore, E.E.,Moore, F.A.,Barnett, C.C., Jr.(1996).Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor.J. Trauma,40,575-579.
2. Boudina, S.,Sena, S.,O''Neill, B.T.,Tathireddy, P.,Young, M.E.,Abel, E.D.(2005).Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity.Circulation,112,2686-2695.
3. Bruemmer-Smith, S.,Avidan, M.S.,Harris, B.,Sudan, S.,Sherwood, R.,Desai, J.B.,Sutherland, F.,Ponte, J.(2002).Glucose, insulin and potassium for heart protection during cadiac surgery.Brit. J. Anaesth.,88,489-495.
4. Buchanan, J.,Mazumder, P.K.,Hu, P.,Chakrabarti, G.,Roberts, M.W.,Yun, Ui.Y.,Cooksey, R.C.,Litwin, S.E.,Abel, E.D.(2005).Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.Endocrinology,146,5341-5349.
5. Bugger, H.,Abel, E.D.(2010).Mitochondria in the diabetic heart.Cardiovasc. Res.,88,229-240.
6. Chen, H.I.,Yeh, D.Y.,Liou, H.L.,Kao, S.J.(2006).Insulin attenuates endotoxin-induced acute lung injury in conscious rats.Crit. Care Med.,34,758-764.
7. Das, U.N.(2002).Is insulin an endogenous cardioprotector?.Crit. Care,6,389-393.
8. Dokka, S.,Shi, X.,Leonard, S.,Wang, L.,Castranova, V.,Rojanasakul, Y.(2001).Interleukin-10-mediated inhibition of free radical generation in macrophages.Am. J. Physiol. Lung Cell. Mol. Physiol.,280,1196-1202.
9. Dorman, B.H.,New, R.B.,Bond, B.R.,Mukherjee, R.,Mukhin, Y.V.,McElmurray, J.H.,Spinale, F.G.(2000).Myocyte endothelin exposure during cardioplegic arrest exacerbates contractile dysfunction after reperfusion.Anaesth. Analg,90,1080-1085.
10. Dowdy, D.W.,Dinglas, V.,Mendez-Tellez, P.A.,Bienvenu, O.J.,Sevransky, J.,Dennison, C.R.,Shanholtz, C.,Needham, D.M.(2008).Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury.Crit. Care Med.,36,2726-2733.
11. Estrada, C.A.,Young, J.A.,Nifong, L.W.,Chitwood, W.R., Jr.(2003).Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting.Ann. Thorac. Surg.,75,1392-1399.
12. Furnary, A.P.,Gao, G.,Grunkemeier, G.L.,Wu, Y.,Zerr, K.J.,Bookin, S.O.,Floten, H.S.,Starr, A.(2003).Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.J. Thorac. Cardiovasc. Surg.,125,1007-1021.
13. Furnary, A.P.,Zerr, K.J.,Grunkemeier, G.L.,Starr, A.(1999).Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.Ann. Thorac. Surg.,67,352-360.
14. Girard, C.,Quentin, P.,Bouvier, H.,Blanc, P.,Bastien, O.,Lehot, J.J.,Mikaeloff, P.,Estanove, S.(1992).Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery: a double-blind study.Ann. Thorac. Surg.,54,259-263.
15. Goldberg, P.A.,Roussel, M.G.,Inzucchi, S.E.(2005).Clinical results of an updated insulin infusion protocol in critically ill patients.Diabetes Spectr.,18,188-191.
16. Hoedemaekers, C.W.,Pickkers, P.,Netea, M.G.,van Deuren, M.,Johannes, G.,Van der Hoeven, J.G.(2005).Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial.Crit. Care,9,790-797.
17. Honiden, S.,Gong, M.N.(2009).Diabetes, insulin, and development of acute lung injury.Crit. Care Med.,37,2455-2464.
18. Kailash, P.K.(2003).C-reactive protein and cardiovascular diseases.Int. J. Angiol.,12,1-12.
19. Knapik, P.,Nadziakiewicz, P.,Urbanska, E.,Saucha, W.,Herdynska, M.,Zembala, M.(2009).Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery.Ann. Thorac. Surg.,87,1859-1865.
20. Krinsley, J.S.(2003).Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.Mayo Clin. Proc.,78,1471-1478.
21. Krinsley, J.S.,Grover, A.(2007).Severe hypoglycemia in critically ill patients: risk factors and outcomes.Crit. Care Med.,35,2262-2267.
22. Liebold, A.,Keylb, C.,Birnbauma, D.E.(1999).The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass.Eur. J. Cardiothorac. Surg.,15,340-345.
23. Mackiewicz, A.,Speroff, T.,Ganapathi, M.K.,Kushner, I.(1991).Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines.J. Immunol.,146,3032-3037.
24. Marik, P.E.,Raghavan, M.(2004).Stress-hyperglycemia, insulin and immunomodulation in sepsis.Intens. Care Med.,30,748-756.
25. Moghissi, E.S.,Korytkowski, M.T.,DiNardo, M.,Einhorn, D.,Hellman, R.,Hirsch, I.B.,Inzuucchi, S.E.,Ismail-Beigi, F.,Kirkman, M.S.,Umpierrez, G.E.(2009).American association of clinical endocrinologists and American association of diabetes association consensus statement on inpatient glycemic control.Endocr. Pract.,4,1-17.
26. Saberi, F.,Heyland, D.,Lam, M.,Rapson, D.,Jeejeebhoy, K.(2008).Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study.J. Parenter. Enter. Nutr.,32,227-235.
27. Singh, U.,Devaraj, S.,Dasu, M.R.,Ciobanu, D.,Reusch, J.,Jialal, I.(2006).C-Reactive Protein decreases Interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production.Arterioscler. Thromb. Vasc. Biol.,26,2469-2475.
28. van den Berghe, G.,Wouters, P.,Weekers, F.,Verwaest, C.,Bruyninckx, F.,Schetz, M.,Vlasselaers, D.,Ferdinande, P.,Lauwers, P.,Bouillon, R.(2001).Intensive insulin therapy in the critically ill patients.N. Engl. J. Med.,345,1359-1367.
29. Van den Berghe, G.,Wouters, P.J.,Bouillon, R.,Weekers, F.,Verwaest, C.,Schetz, M.,Vlasselaers, D.,Ferdinande, P.,Lauwers, P.(2003).Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.Crit. Care Med.,31,359-366.
30. Verma, S.,Maitland, A.,Weisel, R.D.,Li, S.H.,Fedak, P.W.M.,Pomroy, N.C.,Mickle, D.A.G.,Li, R.K.,Ko, L.,Rao, V.(2002).Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism.J. Thorac. Cardiovasc. Surg.,123,1120-1124.
31. Wan, S.,Izzat, M.,Lee, T.W.,Wan, I.Y.,Tang, N.L.,Yim, A.P.(1999).Avoiding cardiopulmonary bypass in multivessel-CABG reduces cytokine response and myocardial injury.Ann. Thorac. Surg.,68,52-57.
32. Wasmuth, H.E.,Kunz, D.,Graf, J.,Stanzel, S.,Purucker, E.A.,Koch, A.,Gartung, C.,Heintz, B.,Gressner, A.M.,Matern, S.,Lammert, F.(2004).Hyperglycemia at admission to the intensive care unit is associated with elevated serum concentrations of interleukin-6 and reduced ex vivo secretion of tumor necrosis factor-alpha.Crit. Care Med.,32,1109-1114.